Startups
BroadOak Capital Partners is a privately held investment bank with a comprehensive focus on the life sciences industry. We offer advisory services including mergers and acquisitions, divestitures, business combinations, joint ventures, valuations and fairness opinions. We also engage in principal investment activities, including co-investments, as particularly compelling opportunities arise. Our sector focus includes research tools and consumables, diagnostics, therapeutics, healthcare IT, pharmaceutical services and medical devices.
BroadOak provides multinational corporations, middle-market and entrepreneurial clients with the customized attention of a boutique while delivering a range of expertise more typically associated with a larger firm. Our industry focus allows the firm’s principals to target their investment banking experience and insight to specific client needs.
BroadOak provides multinational corporations, middle-market and entrepreneurial clients with the customized attention of a boutique while delivering a range of expertise more typically associated with a larger firm. Our industry focus allows the firm’s principals to target their investment banking experience and insight to specific client needs.
Overview
Location
United States, California, Brisbane
Employees
11-50
Founded date
2006
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 30, 2026 | Opentrons Raises $40 Million Series E To Expand AI-Driven Laboratory Automation | Opentrons Labworks has raised $40 million in Series E funding to expand its robotics, software, and data infrastructure for AI-driven scientific experimentation. Healthcare investment firm Avego led the round, with additional participation ... |
| Sep 14, 2026 | NaviMed Capital Appoints Holly Atallah as Chief Financial Officer, Promotes Bennett Mears to Principal, and Grows Team with New Hires | Firm expands its finance, investment, and operations functions with three new hires and a promotion. WASHINGTON, Sept. 14, 2026 /PRNewswire-PRWeb/ -- NaviMed Capital, a healthcare-focused private equity firm based in the Washington, DC area... |
| Apr 14, 2026 | Quartzy Raises $23M in Funding | Quartzy, a Hayward, CA-based provider of a vertically-integrated procurement platform for the life sciences industry, raised $23M in funding. The round was led by Avenue Capital Group and BroadOak Capital Partners. The company intends to us... |
| Nov 14, 2025 | BroadOak Capital Partners Announces New Investments Across Life Sciences Portfolio | BroadOak Capital Partners has announced a series of new growth investments that expand its life sciences platform and reinforce its position as a long-term partner to emerging industry leaders. The activity includes the first investment fro... |
| Oct 29, 2025 | BroadOak Capital Partners Adds $200 Million In Permanent Capital | BroadOak Capital Partners, a life sciences-focused investment and advisory firm, has secured more than $200 million in permanent capital, expanding its capacity to invest flexibly across the life sciences ecosystem. The new capital strength... |
| Oct 16, 2025 | Codis Receives Growth Capital | Codis, a St. Louis, Missouri-based CDMO focused on commercial spray drying, amorphous solid dispersions (ASD), particle engineering, and finished-dose manufacturing, received a growth investment from 1315 Capital, with participation from ex... |
| Aug 22, 2025 | KROMATID: $8 Million Series C Raised For Genomic Structural Analysis | KROMATID, a pioneering force in next-generation genomic structural analysis, announced the completion of its Series C funding round, which has raised a total of $8 million, significantly exceeding its initial capital goals. The latest tranc... |
| Jul 28, 2025 | Pluristyx Closes Investment Round | Pluristyx, a Seattle, WA-based provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, closed its funding. The amount of the deal was not disclosed. The round was led by BioLife Solutions and Br... |
| Jan 6, 2025 | PBS Biotech: $17 Million In Growth Capital Raised | PBS Biotech – a provider of single-use bioreactor systems and bioprocess development services – announced it secured $17 million in follow-on growth capital from Avego Management and BroadOak Capital Partners. These funds will advance PBS’ ... |
Show more
Reviews 0
FAQ about BroadOak Capital Partners
When was BroadOak Capital Partners founded?
BroadOak Capital Partners was founded in 2006.
What has the press written about BroadOak Capital Partners?
Parsers VC has collected 15 articles mentioning BroadOak Capital Partners, among them “Opentrons Raises $40 Million Series E To Expand AI-Driven Laboratory Automation” (Oct 30, 2026) and “NaviMed Capital Appoints Holly Atallah as Chief Financial Officer, Promotes Bennett Mears to Principal, and Grows Team with New Hires” (Sep 14, 2026).
Is BroadOak Capital Partners still active?
Yes, BroadOak Capital Partners is active; its latest activity on Parsers VC dates from Nov 6, 2026.